Systematic review shows nicotine e-cigarettes improve smoking cessation rates compared to NRT — Evidence Review
Published in Cochrane Database of Systematic Reviews, by researchers from University of Massachusetts Amherst, University of Oxford
Researched by
— the AI search engine for science
Table of Contents
Smokers trying to quit are more likely to succeed using nicotine e-cigarettes than with traditional nicotine replacement therapies (NRT) such as patches or gum, according to a comprehensive systematic review. This finding is generally supported by related studies, though some prior research noted only modest or uncertain differences between these methods; see the Cochrane Database of Systematic Reviews for details.
- Multiple randomized controlled trials and meta-analyses have found nicotine e-cigarettes to be as effective or more effective than NRT for smoking cessation, but some earlier studies reported only modest or statistically uncertain advantages, highlighting shifts in evidence over time and across study designs 1 2 4 12.
- Recent network meta-analyses and systematic reviews suggest that both e-cigarettes and combined pharmacologic therapies increase quit rates compared to usual care, but the certainty of evidence for e-cigarettes remains lower due to study heterogeneity and potential biases 5 12.
- Some cohort and population-based studies have raised concerns about the real-world effectiveness and possible risks of e-cigarettes for cessation, suggesting that while e-cigarettes may help certain individuals quit, broader public health impacts and long-term safety require further investigation 3 10 11.
Study Overview and Key Findings
Tobacco use remains the leading cause of preventable illness and death globally, and finding effective methods to help smokers quit is a persistent public health priority. This new living systematic review examines whether nicotine e-cigarettes are more effective than traditional NRT or behavioral support in aiding cessation, a question with significant implications given the growing popularity of vaping and ongoing debates about its safety and efficacy. The inclusion of 80 randomized controlled trials, with nearly 30,000 participants, makes this one of the most comprehensive analyses to date on the topic.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | University of Massachusetts Amherst, University of Oxford |
| Journal Name | Cochrane Database of Systematic Reviews |
| Authors | Nicola Lindson, Jonathan Livingstone-Banks, Ailsa R Butler, Hayden McRobbie, Christopher R Bullen, Peter Hajek, Angela Difeng Wu, Rachna Begh, Annika Theodoulou, Claire Ma, Caitlin Notley, Nancy A Rigotti, Tari Turner, Thomas Fanshawe, Jamie Hartmann-Boyce |
| Population | Smokers trying to quit |
| Sample Size | 80 randomized controlled trials with 29,861 participants |
| Methods | Systematic Review |
| Outcome | Quit rates among smokers using different cessation methods |
| Results | Nicotine e-cigarettes led to 4 more quitters per 100 than NRT. |
Literature Review: Related Studies
To contextualize the new findings, we searched the Consensus paper database, which contains over 200 million research papers. The following search queries were used to identify relevant literature:
- nicotine e-cigarettes quit smoking effectiveness
- NRT comparison smoking cessation methods
- e-cigarettes vs nicotine patches quit rates
Below, we organize related research into major topics and summarize key findings.
| Topic | Key Findings |
|---|---|
| Are nicotine e-cigarettes more effective than NRT for smoking cessation? | - Several RCTs and meta-analyses show nicotine e-cigarettes are at least as effective, and often more effective, than NRT (patches, gum) for smoking cessation 1 2 4 12. - Some studies note only modest improvements or statistically uncertain differences between these methods 2 5. |
| What are the safety and health risks of nicotine e-cigarettes compared to other cessation aids? | - Both e-cigarettes and NRT are associated with minor adverse effects (mouth/throat irritation for e-cigarettes, skin/mouth irritation for NRT) and rare serious adverse events; current evidence does not suggest major short-term harms for regulated products 2 4 5 8. - Long-term safety data for e-cigarettes remains limited and concerns exist regarding potential health risks and youth uptake 3 10 11. |
| How do behavioral support and combined therapies impact quit rates? | - Combining pharmacologic aids (e.g., varenicline and NRT) or behavioral support with cessation treatments increases quit rates compared to pharmacologic therapies alone 5 6 7 10. - Behavioral interventions are effective, especially when paired with pharmacotherapy, but may be less effective on their own compared to nicotine e-cigarettes or combination therapies 10. |
| What is the real-world effectiveness and population impact of e-cigarettes for quitting? | - Some population-based cohort studies have not found a strong association between e-cigarette use and successful quitting, raising questions about their effectiveness outside of trial settings 3 11. - Meta-analyses and RCTs generally report higher quit rates in controlled settings, suggesting that context and support may affect success 1 12. |
Are nicotine e-cigarettes more effective than NRT for smoking cessation?
Research over the past decade has increasingly found that nicotine e-cigarettes may offer higher quit rates than traditional NRT, though the magnitude and certainty of this benefit varies. The new systematic review's finding—that nicotine e-cigarettes produced about four additional quitters per 100 compared with NRT—is supported by several recent RCTs and meta-analyses, although some earlier studies found only modest or statistically uncertain differences.
- Multiple RCTs have shown that e-cigarettes outperform NRT in supporting sustained abstinence over 6-12 months 1 12.
- Earlier studies sometimes found only modest or non-significant differences, likely due to limited power or smaller sample sizes 2.
- Network meta-analyses confirm that both e-cigarettes and NRT are more effective than placebo or usual care, but e-cigarettes may offer a moderate additional benefit 5 12.
- The advantage of e-cigarettes over NRT appears consistent when behavioral support is provided alongside both interventions 1.
What are the safety and health risks of nicotine e-cigarettes compared to other cessation aids?
While both nicotine e-cigarettes and NRT products have been associated with minor side effects, current evidence suggests that serious adverse events are rare when regulated products are used. However, the long-term health effects of e-cigarette use remain uncertain, and concerns have been raised about youth uptake and potential gateway effects.
- Short-term use of both e-cigarettes and NRT is generally safe, with most adverse effects being mild and product-specific (e.g., throat irritation for e-cigarettes, skin irritation for patches) 2 4 8.
- Meta-analyses and systematic reviews report no significant increase in serious adverse events for e-cigarettes or NRT compared to placebo 2 4 8.
- Long-term safety data are lacking for e-cigarettes, and health organizations advise caution, particularly regarding potential risks for young people and non-smokers 3 10 11.
- Some studies suggest that behavioral support and regulated products are key to minimizing risks and maximizing benefits 4 10.
How do behavioral support and combined therapies impact quit rates?
The effectiveness of smoking cessation interventions is often enhanced by combining pharmacologic treatments with behavioral support or by using combination therapies. The new review found higher quit rates with e-cigarettes compared to behavioral support alone, but also emphasized that regulated products and professional guidance are important for safety and success.
- Combined behavioral and pharmacologic interventions are consistently more effective than either approach alone 5 6 7 10.
- Within pharmacologic therapies, combined NRT products (e.g., patch plus gum) or combining varenicline with NRT have shown the highest quit rates 5 9.
- Behavioral interventions alone can aid cessation, but their effectiveness is typically lower than that of pharmacologic or combination therapies 10.
- Real-world quit rates may be lower than those observed in clinical trials, highlighting the importance of ongoing support 11.
What is the real-world effectiveness and population impact of e-cigarettes for quitting?
Despite promising results from RCTs and meta-analyses, some population-based studies have not found a strong association between e-cigarette use and successful quitting. This discrepancy suggests that effectiveness may depend on factors such as user motivation, access to regulated products, and behavioral support.
- Cohort studies have sometimes failed to detect higher quit rates among e-cigarette users in the general population, contrasting with controlled trial results 3 11.
- RCTs and meta-analyses generally show greater effectiveness for e-cigarettes than NRT, but trial conditions may not reflect real-world usage patterns 1 12.
- The risk of bias and heterogeneity in study designs complicates direct comparisons and may explain some of the variation in findings 5 12.
- Public health impact will depend on broader patterns of use, regulation, and the balance between cessation support and potential uptake by non-smokers or youth 3 10 11.
Future Research Questions
Although the new systematic review advances understanding of the comparative effectiveness of nicotine e-cigarettes and NRT, important gaps remain. Future research should address the long-term safety of e-cigarettes, their effectiveness in real-world settings, and strategies for supporting cessation among diverse populations. Greater focus is also needed on how best to transition users from e-cigarettes to complete nicotine abstinence.
| Research Question | Relevance |
|---|---|
| What are the long-term health effects of nicotine e-cigarette use in smokers who have quit smoking? | Long-term safety data for e-cigarettes remains limited, and understanding potential risks is crucial for both clinical practice and public health policy 3 10 11. |
| How effective are nicotine e-cigarettes for smoking cessation in real-world population-based settings? | Real-world observational studies have reported lower effectiveness than RCTs, highlighting the need to bridge the gap between clinical trials and everyday use 3 11. |
| What strategies can help people quit using nicotine e-cigarettes after quitting smoking? | Many people transition from smoking to vaping but may remain dependent on nicotine; research on subsequent cessation of e-cigarette use is lacking [news article]. |
| How do different forms of behavioral support influence the effectiveness of e-cigarettes and NRT for smoking cessation? | Integrating behavioral support with pharmacologic aids (including e-cigarettes and NRT) appears to enhance quit rates, but optimal support strategies remain to be clarified 5 6 7 10. |
| What are the risks of nicotine e-cigarette uptake among youth and non-smokers in the context of cessation programs? | While e-cigarettes may support cessation in adults, their availability has raised concerns about increased nicotine addiction among youth and unintended uptake by non-smokers 3 10 11. |
This article provides an evidence-based summary of current research on nicotine e-cigarettes and NRT for smoking cessation, highlighting both consensus and ongoing debates in the scientific literature. As new studies emerge, continued evaluation of both efficacy and safety will be essential for guiding clinical recommendations and public health strategies.